name: | Cabergoline |
ATC code: | G02CB03 | route: | oral |
n-compartments | 2 |
Cabergoline is a long-acting dopamine D2 receptor agonist used primarily for the treatment of hyperprolactinemia and disorders associated with prolactin excess. It is also sometimes used off-label for Parkinson's disease. Cabergoline is approved and in clinical use today.
Pharmacokinetic parameters reported in healthy adult volunteers of both sexes after oral administration.